China Pharma Hold…

About the company

Website

chinapharmaholdings.com

Investor relations

chinapharmaholdings.com/InvestorRelations/StockInformation

Sector

Health Care · Biotechnology: Pharmaceutical Preparations

Headquarters

HAINAN PROVINCE

Shares outstanding

43.02 M as of 2026-08-11

Year: +6.2% · 3 years: +5.1% · 5 years: +68.3% (excluding splits)

Date	Shares	Change
11.08.2026	43.02 M	+6.2%	issuance (dilution)
11.05.2026	40.52 M	—	no significant change
25.03.2026	40.52 M		split 8:1
10.11.2025	5.02 M		split 1.5:1
07.08.2025	3.26 M	—	no significant change
14.05.2025	3.26 M		reverse split 1:10
24.03.2025	32.62 M	+69.4%	issuance (dilution)
12.11.2024	19.25 M	+12.2%	issuance (dilution)
12.08.2024	17.16 M	+15.8%	issuance (dilution)
24.03.2024	14.82 M	−55.0%	buyback
10.11.2023	32.95 M		split 3:1
07.08.2023	11.43 M	+17.4%	issuance (dilution)
09.05.2023	9.74 M	+15.1%	issuance (dilution)
24.03.2023	8.46 M		reverse split 1:6
09.11.2022	51.64 M	+2.4%	issuance (dilution)

Share count from the company reports. A split is detected by a jump in the count by a whole number of times.

Industry (SIC)

Pharmaceutical Preparations

P/E

loss

FCF

—

Debt

3.60 M USD

Earnings and FCF — for the 12 months to 30.06.2026 (the company's latest report).

NAV

0.89 USD · P/NAV 0.82

Balance sheet date	30.06.2026
Assets	44.7 M USD
− Liabilities	8.53 M USD
= NAV (equity of the company's shareholders)	36.2 M USD
− Intangible assets	38.3 M USD
= Tangible NAV	−2.16 M USD
Shares	40 522 002
NAV per share	0.89 USD
Tangible NAV per share	−0.05 USD
Share price (CPHI)	0.7279 USD
P/NAV	0.82

NAV history

Balance sheet date	NAV	NAV per share
30.06.2026	36.2 M USD	0.89 USD
31.03.2026	37.0 M USD	0.91 USD
31.12.2025	22.7 M USD	4.12 USD
30.09.2025	8.31 M USD	2.55 USD
30.06.2025	6.46 M USD	1.98 USD
31.03.2025	6.97 M USD	2.14 USD
31.12.2024	7.75 M USD	2.38 USD
30.09.2024	6.53 M USD	0.37 USD